Outcome of selected breast cancer patients with micrometastasis or isolated tumor cells in sentinel node biopsy and no completion axillary lymph node dissection

Axillary lymph node dissection (ALND) is the standard of care in patients with tumor‐positive sentinel nodes (SN). However, approximately half of these patients do not have additional metastases in their axilla and therefore do not benefit from completion ALND. Our aim was to examine the outcome of highly selected breast cancer patients with tumor‐positive SN without completion ALND.

[1]  B. Esterni,et al.  A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  O. Nieweg,et al.  Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  P. V. van Diest,et al.  Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. , 2008, Journal of the National Cancer Institute.

[4]  A. Soran,et al.  Models for predicting non‐sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system , 2008, International journal of clinical practice.

[5]  J. Donohue,et al.  Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different? , 2008, Surgery.

[6]  Solomon Henry,et al.  New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients , 2008, BMC Cancer.

[7]  A. Purushotham,et al.  A model for predicting non‐sentinel lymph node metastatic disease when the sentinel lymph node is positive , 2008, The British journal of surgery.

[8]  D. Boulware,et al.  Significance of sentinel lymph node micrometastases in human breast cancer. , 2008, Journal of the American College of Surgeons.

[9]  E. Balslev,et al.  Sentinel node biopsy in breast cancer: Five years experience from Denmark , 2008, Acta oncologica.

[10]  Diane D. Liu,et al.  Low locoregional failure rates in selected breast cancer patients with tumor‐positive sentinel lymph nodes who do not undergo completion axillary dissection , 2007, Cancer.

[11]  H. Cody,et al.  A Declining Rate of Completion Axillary Dissection in Sentinel Lymph Node-positive Breast Cancer Patients Is Associated With the Use of a Multivariate Nomogram , 2007, Annals of surgery.

[12]  P. Rouanet,et al.  Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Jorma Isola,et al.  Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. , 2006, The New England journal of medicine.

[14]  T. Toivonen,et al.  Rapid immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma , 2005, Cancer.

[15]  P. Schrenk.  Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy , 2005, European Surgery.

[16]  T. Toivonen,et al.  Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  Antoine Flahault,et al.  An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement , 2005, Breast Cancer Research and Treatment.

[18]  P. Heikkilä,et al.  The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  R. Walker,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .

[20]  A. Sapino,et al.  Meta‐analysis of non‐sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer , 2004, The British journal of surgery.

[21]  H. Cody,et al.  The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection: A Follow-up Study of 4008 Procedures , 2004, Annals of surgery.

[22]  Hiram S. Cody,et al.  A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy , 2003, Annals of Surgical Oncology.

[23]  J. Kuhn,et al.  Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary Dissection , 2003, Annals of Surgical Oncology.

[24]  A. Giuliano,et al.  Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. , 2001, Seminars in surgical oncology.

[25]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[26]  PhD Marjut H. K. Leidenius MD,et al.  Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer , 2009, Annals of Surgical Oncology.

[27]  D. Winchester.  Sentinel node positive breast cancer patients who do not undergo axillary dissection: Are they different? , 2009 .

[28]  E. Barrera,et al.  Axillary Recurrence After Sentinel Node Biopsy , 2004, Annals of Surgical Oncology.

[29]  A. Giuliano,et al.  Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. , 2003, Archives of surgery.

[30]  R. Orr.  The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival—A Bayesian Meta-Analysis , 1999, Annals of surgical oncology.